Their ability to slow gastric movements and curb appetite allows patients struggling with weight management to shed pounds under a health professionals supervision and expertise
Please note that questions regarding fulfillment, customer service, privacy policies, or issues relating to your book orders should be directed to the Webmaster or administrator of the specific bookseller's site and are their sole responsibility
First, because of the relatively limited number of studies about semaglutide treating obesity without diabetes, one of our studies was divided into seven separate trials for analyses, which might affect the homogeneity and publication bias
Limitations The study has a limited number of participants (90 patients), which may restrict the generalizability of the results to the broader population
Fact: While GLP-1 medications were originally designed for people with type 2 diabetes, they are now widely used for weight management in individuals without diabetes
+ view all (2022) Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial